Detail of the clinical trial

Title of the trial A Randomized, Double-Blind, Placebo Controlled, Phase 3 Study of Venetoclax in Combination with Azacitidine Versus Azacitidine in Treatment Na?ve Subjects with Acute Myeloid Leukemia who are Ineligible for Standard Induction Therapy
EudraCT number 2016-001466-28
Protocol number M15-656
Sponsor AbbVie Deutschland GmbH & Co. KG, Knollstrasse, 67061 Ludwigshafen, Germany
Indications Hemato-oncology
Diagnosis Acute Myeloid Leukemia
Population in clinical trial Adults (18-65 years)
Elderly ( > 65 years)
Male
Female
Patients
Year of receiving the request to Institute (SÚKL) 2017
Date of approval by Institute (SÚKL) 8.6.2017
Date of approval by EC 27.9.2017
Date of initiation CT in ČR 15.12.2017
Date of ending CT in ČR
Notice
Sites FN Hradec Králové,IV. interní heamtologická klinika,Sokolovská 581,Hradec Králové,500 05
FN Plzeň,Hematologicko-onkolpogické oddělení,Alej Svobody 80,Plzeň,304 60
FN Ostrava,Hematoonkologická klinika,17. listopadu 1790,Ostrava,708 52
FN Brno,Interní hematologická a onkologická klinika,Jihlavská 20,Brno,625 00

‹‹ Back to list